167 related articles for article (PubMed ID: 27861750)
21. Sirt1 induction confers resistance to etoposide-induced genotoxic apoptosis in thyroid cancers.
Kweon KH; Lee CR; Jung SJ; Ban EJ; Kang SW; Jeong JJ; Nam KH; Jo YS; Lee J; Chung WY
Int J Oncol; 2014 Nov; 45(5):2065-75. PubMed ID: 25109285
[TBL] [Abstract][Full Text] [Related]
22. Notch3/Jagged1 circuitry reinforces notch signaling and sustains T-ALL.
Pelullo M; Quaranta R; Talora C; Checquolo S; Cialfi S; Felli MP; te Kronnie G; Borga C; Besharat ZM; Palermo R; Di Marcotullio L; Capobianco AJ; Gulino A; Screpanti I; Bellavia D
Neoplasia; 2014 Dec; 16(12):1007-17. PubMed ID: 25499214
[TBL] [Abstract][Full Text] [Related]
23. Patterns of expression of cell cycle/apoptosis genes along the spectrum of thyroid carcinoma progression.
Saltman B; Singh B; Hedvat CV; Wreesmann VB; Ghossein R
Surgery; 2006 Dec; 140(6):899-905; discussion 905-6. PubMed ID: 17188136
[TBL] [Abstract][Full Text] [Related]
24. Regulation of pancreatic stellate cell activation by Notch3.
Song H; Zhang Y
BMC Cancer; 2018 Jan; 18(1):36. PubMed ID: 29304760
[TBL] [Abstract][Full Text] [Related]
25. Expressions and Prognostic Values of Notch3 and DLL4 in Human Breast Cancer.
Wang L; Cao G; Li W; Chen XW; Xiong SS; Mu YN; Jiang JF; Yang L; Zhang DR; Cao YW
Technol Cancer Res Treat; 2023; 22():15330338221118984. PubMed ID: 36740988
[No Abstract] [Full Text] [Related]
26. SIN1, a critical component of the mTOR-Rictor complex, is overexpressed and associated with AKT activation in medullary and aggressive papillary thyroid carcinomas.
Moraitis D; Karanikou M; Liakou C; Dimas K; Tzimas G; Tseleni-Balafouta S; Patsouris E; Rassidakis GZ; Kouvaraki MA
Surgery; 2014 Dec; 156(6):1542-8; discussion 1548-9. PubMed ID: 25456951
[TBL] [Abstract][Full Text] [Related]
27. Association between high levels of Notch3 expression and high invasion and poor overall survival rates in pancreatic ductal adenocarcinoma.
Zhou JX; Zhou L; Li QJ; Feng W; Wang PM; Li EF; Gong WJ; Kou MW; Gou WT; Yang YL
Oncol Rep; 2016 Nov; 36(5):2893-2901. PubMed ID: 27633819
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
[TBL] [Abstract][Full Text] [Related]
29. Notch3 drives development and progression of cholangiocarcinoma.
Guest RV; Boulter L; Dwyer BJ; Kendall TJ; Man TY; Minnis-Lyons SE; Lu WY; Robson AJ; Gonzalez SF; Raven A; Wojtacha D; Morton JP; Komuta M; Roskams T; Wigmore SJ; Sansom OJ; Forbes SJ
Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12250-12255. PubMed ID: 27791012
[TBL] [Abstract][Full Text] [Related]
30. NOTCH3 signaling regulates MUSASHI-1 expression in metastatic colorectal cancer cells.
Pastò A; Serafin V; Pilotto G; Lago C; Bellio C; Trusolino L; Bertotti A; Hoey T; Plateroti M; Esposito G; Pinazza M; Agostini M; Nitti D; Amadori A; Indraccolo S
Cancer Res; 2014 Apr; 74(7):2106-18. PubMed ID: 24525742
[TBL] [Abstract][Full Text] [Related]
31. Notch3 signaling is associated with MUC5AC expression and favorable prognosis in patients with small intestinal adenocarcinomas.
Eom DW; Hong SM; Kim J; Kim G; Bae YK; Jang KT; Yu E
Pathol Res Pract; 2014 Aug; 210(8):501-7. PubMed ID: 24810798
[TBL] [Abstract][Full Text] [Related]
32. Id1 gene expression is up-regulated in hyperplastic and neoplastic thyroid tissue and regulates growth and differentiation in thyroid cancer cells.
Kebebew E; Peng M; Treseler PA; Clark OH; Duh QY; Ginzinger D; Miner R
J Clin Endocrinol Metab; 2004 Dec; 89(12):6105-11. PubMed ID: 15579766
[TBL] [Abstract][Full Text] [Related]
33. Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinoma.
Giovannini C; Minguzzi M; Baglioni M; Fornari F; Giannone F; Ravaioli M; Cescon M; Chieco P; Bolondi L; Gramantieri L
Oncotarget; 2014 Nov; 5(21):10607-20. PubMed ID: 25431954
[TBL] [Abstract][Full Text] [Related]
34. The NOTCH3 Downstream Target HEYL Is Required for Efficient Human Airway Basal Cell Differentiation.
Bodas M; Subramaniyan B; Moore AR; Metcalf JP; Ocañas SR; Freeman WM; Georgescu C; Wren JD; Walters MS
Cells; 2021 Nov; 10(11):. PubMed ID: 34831437
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of DEP domain containing mTOR-interacting protein correlates with poor prognosis in differentiated thyroid carcinoma.
Pei L; Xie P; Zhou E; Yang Q; Luo Y; Tang Z
Mol Med Rep; 2011; 4(5):817-23. PubMed ID: 21643629
[TBL] [Abstract][Full Text] [Related]
36. cMYC expression in thyroid follicular cell-derived carcinomas: a role in thyroid tumorigenesis.
Sakr HI; Chute DJ; Nasr C; Sturgis CD
Diagn Pathol; 2017 Oct; 12(1):71. PubMed ID: 28974238
[TBL] [Abstract][Full Text] [Related]
37. Mitochondrial DNA mutations in differentiated thyroid cancer with respect to the age factor.
Witte J; Lehmann S; Wulfert M; Yang Q; Röher HD
World J Surg; 2007 Jan; 31(1):51-9. PubMed ID: 17171498
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-7a regulates Müller glia differentiation by attenuating Notch3 expression.
Baba Y; Aihara Y; Watanabe S
Exp Eye Res; 2015 Sep; 138():59-65. PubMed ID: 26122050
[TBL] [Abstract][Full Text] [Related]
39. Notch3 signalling promotes tumour growth in colorectal cancer.
Serafin V; Persano L; Moserle L; Esposito G; Ghisi M; Curtarello M; Bonanno L; Masiero M; Ribatti D; Stürzl M; Naschberger E; Croner RS; Jubb AM; Harris AL; Koeppen H; Amadori A; Indraccolo S
J Pathol; 2011 Aug; 224(4):448-60. PubMed ID: 21598247
[TBL] [Abstract][Full Text] [Related]
40. Dual epidermal growth factor receptor and vascular endothelial growth factor receptor inhibition with NVP-AEE788 for the treatment of aggressive follicular thyroid cancer.
Younes MN; Yazici YD; Kim S; Jasser SA; El-Naggar AK; Myers JN
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3425-34. PubMed ID: 16740767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
